This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A balanced review of the status T cell-based therapy against cancer
Journal of Translational Medicine Open Access 14 April 2005
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rosenberg, S.A., Yang, J.C. & Restifo, N.P. Nat. Med. 10, 909–915 (2004).
Miller, A.B., Hoogstraten, B., Staquet, M & Winkler, A. Cancer 47, 207–214 (1981).
Therasse, P. et al. J. Natl. Cancer Inst. 92, 205–216 (2000).
Dudley, M.E. et al. Science 298, 850–854 (2002).
Overwijk, W.W. et al. J. Exp. Med. 198, 569–580 (2003).
Klebanoff, C.A. et al. Proc. Natl. Acad. Sci. USA 101, 1969–1974 (2004).
Rosenberg, S.A. & Dudley, M.E. Proc. Natl. Acad. Sci. USA 101, 14639–14645 (2004).
Timmerman, J.M. et al. Blood 99, 1517–1526 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosenberg, S., Yang, J. & Restifo, N. Reply to "Cancer vaccines: pessimism in check". Nat Med 10, 1279–1280 (2004). https://doi.org/10.1038/nm1204-1279b
Issue Date:
DOI: https://doi.org/10.1038/nm1204-1279b
This article is cited by
-
Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy
Clinical & Experimental Metastasis (2014)
-
VRP immunotherapy targeting neu: treatment efficacy and evidence for immunoediting in a stringent rat mammary tumor model
Breast Cancer Research and Treatment (2007)
-
A balanced review of the status T cell-based therapy against cancer
Journal of Translational Medicine (2005)
-
Recent developments in therapeutic cancer vaccines
Nature Clinical Practice Oncology (2005)